DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Janssen Biotech
Janssen Biotech
From the Academy
Nct02497287
Nct03333317
2015 Annual Report
Johnson & Johnson Has Made a New Breakthrough In
FDA Listing of Authorized Generics As of July 1, 2021
ASN Kidney Week 2020 Reimagined: Disclosures Page 1
Annual Report
Protagonist Therapeutics Names Samuel Saks, M.D., As Chief Development Officer
Satu Glawe Phone: 49-172-294-6264
2016 Annual Report
Scientific Review of Janssen Biotech Inc. COVID-19 Vaccine (Ad26.COV2.S) March 1, 2021
1 in the United States District Court for the Western
Johnson & Johnson Innovation Champions Leading Edge Science with 15 New Collaborations with Potential to Impact Patients'
In the United States District Court for the District of Massachusetts
Johnson & Johnson
LSPA-2020-Annual-Report-Final.Pdf
Manufacturers and Wholesalers Street City ST Zip Acorda Therapeutics
Top View
Johnson & Johnson Annual Report 2021
Johnson & Johnson 2016 Annual Report
Annual Report: 2017
Sharps Disposal Plan
Drug Companies Participating in MED-Project Stewardship Plan (February 9, 2017)
1 News Release Media Contacts
Older Americans, Please See Medi- See Please Ing Older Americans, Ameri- for Older Cines in Development
Study Protocol
Johnson & Johnson
Health Advisory Janssen (Johnson & Johnson) COVID-19 Vaccine
1:20-Cv-03471 Document #: 370 Filed: 02/03/21 Page 1 of 27 Pageid #:27504
20200915 MED-Project Participant List.Xlsx
2020 Annual Report • • Failure to Meet Compliance Obligations in the Mcneil-PPC, Inc
Contract Drugs List Part 1 – Prescription Drugs (A Through D) Page Updated: November 2020
Johnson & Johnson
2019 Janssen U.S. Transparency Report Notes on This Report
EXHIBIT 21 SUBSIDIARIES Johnson & Johnson, a New Jersey
Faculty Disclosure Index DDW Sponsoring Society CME Statements
1 Media Inquiries: Suzanne Frost Phone
Drug Deilvery & Formulation 2020 Part 2.Indd
Johnson & Johnson
Colloquium Issue Creating Five-Star Care Coordination, P.36 CAPG
Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral
Johnson & Johnson – Account Deep Dive Analysis
Industry Company Profile Fall 2012
ASN Kidney Week 2019 Disclosures 1